Article Information
History
- April 25, 2021.
Article Versions
- Version 1 (December 26, 2020 - 01:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shay Ben Shachar1,2,3,
- Noam Barda2,4,
- Sigal Manor5,
- Sapir Israeli7,
- Noa Dagan2,4,
- Adam Haber6,
- Shai Carmi7,
- Ran Balicer2,
- Bracha Zisser5 and
- Yoram Louzoun8,*
- 1Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv; Israel
- 2Clalit Research Institute, Ramat Gan, Israel,
- 3Schneider Children’s Medical Center, Petah Tikva, Israel
- 4Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA
- 5Ezer Mizion Bone Marrow Donor Registry, Petah-Tikva, Israel
- 6Department of Neurobiology, Weizmann Institute of Science, Rehovot, Israel
- 7Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
- 8Department of Mathematics, Bar Ilan University, Ramat Gan, Israel.
- ↵*Correspondence
Correspondence and requests should be sent to: Yoram Louzoun - Department of Mathematics, Bar Ilan University, Ramat Gan, Israel, email – louzouy{at}math.biu.ac.il
Posted April 25, 2021.
MHC Haplotyping of SARS-CoV-2 patients: HLA subtypes are not associated with the presence and severity of Covid-19 in the Israeli population
